TRIO - Translational Research in Oncology

TRIO is a leading oncology clinical research organization (CRO) dedicated to accelerating drug development through translational research. With decades of experience conducting comprehensive oncology trials from inception to completion, TRIO leverages a global network of investigators and academic leaders to bring innovative therapies to clinics on the most rational path. Focused on saving lives with efficiency and care, they deliver targeted concepts with a commitment to excellence.